As aging baby boomers are reaching the age of risk for Alzheimer's, the federal funding for research on aging diseases has been sorely inadequate, and it's time for the government to increased investment in research to better treat, prevent and cure diseases such as Alzheimer's, according to a new report released by the Alzheimer's Foundation of America (AFA).
In Science/Business article CAF's Henry McCance discusses how he used his venture capital expertise to take on finding a cure for Alzheimer's after his wife was diagnosed with the disease 10 years ago.
McCance co-founded Cure Alzheimer's Fund explaining “the model for funding academic research was insufficient, inefficient and ineffective.” McCance hopes this concept of venture research will catch on.
NY Times online columnist David Bornstein examines how the Cure Alzheimer's Fund and other organizations have taken a unique approach to research that is intensely goal-directed and collaborative, focusing on the creation of new cures and potential treatment as a process that needs to be managed. Bornstein notes the Fund has worked to bring a sense of urgency to their research that is resulted oriented.
Cure Alzheimer's Fund's $100,000 grant to Rockefeller University's Dr. Paul Greengard was featured in USA Today online "Charity in the News: Week in Review." The Nobel Laureate will use the grant to continue his studies on identifying brains cells that are vulnerable to Alzheimer’s. His studies could lead to the development of protective drugs targeted at those specific cells.
On May 19, 2011, Glenn Caffery, age 49, set out from Seaside, Ore., to run 3,312 miles across the country to Westerly, R.I. He is running to honor his father—Dick Caffery—whom he lost to Alzheimer’s disease in 2002, and to raise money to help find a cure for this devastating illness. “Watching my father suffer made me feel so helpless,” says Caffery. “Since he’s passed away, I’ve felt like I needed to do something to help, and running across the country felt like something.”
Distance Runner to Raise Awareness, Research Funding for Alzheimer’s on 3,300-Mile Journey from Oregon to Rhode Island
Seaside, Oregon – Setting out on a 3,300-mile run from Seaside, Ore., to Westerly, R.I. to raise money and public awareness of Alzheimer’s disease, veteran distance runner and advocate Glenn Caffery compares the rigors of long distance running to the challenges facing 5.2 million Americans and their families who are dealing with the debilitating disease.
The 7 Summits Climb for Alzheimer’s: Memories are Everything is a year-long challenge by mountain climber and Alzheimer’s disease advocate Alan Arnette to scale the 7 summits, the highest peak on each continent. Alan is striving to raise $1 million to advance Alzheimer’s research, and provide support for family caregivers and all those affected by Alzheimer’s disease.
Nobel laureate Paul Greengard, a Rockefeller University professor has been awarded a $100,000 grant by Cure Alzheimer’s Fund to continue his groundbreaking research on Alzheimer’s disease, the most common cause of dementia in the elderly that currently affects 5.2 million Americans and their families.
Paul Greengard, Ph.D., will use the grant to continue his studies on identifying brains cells that are vulnerable to Alzheimer’s. His studies could lead to the development of protective drugs targeted at those specific cells.
Boston - A University of Virginia professor has been awarded a $100,000 grant by Cure Alzheimer’s Fund to continue his groundbreaking research on Alzheimer’s disease, the most common cause of dementia in the elderly, which currently affects 5.2 million Americans and their families.
George S. Bloom, Ph.D., will use the grant to continue his studies on a strain of antibodies thought to be able to recognize the proteins associated with Alzheimer’s.